Showing results (51-60 of 165) with videos related to
Sort By:
Pageof 17
Breast Cancer Research and Treatment|September 1, 1988
Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patientsH J Helin, J J Isola, M J Helle, et al.Anticancer Research|May 23, 2002
Expression of C-KIT and HER-2 tyrosine kinase receptors in poor-prognosis breast cancerS Palmu, K O Söderström, K Quazi, et al.Clinical and Experimental Immunology|September 25, 2007
Gluten affects epithelial differentiation-associated genes in small intestinal mucosa of coeliac patientsK Juuti-Uusitalo, M Mäki, H Kainulainen, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 1, 1992
Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomasT Visakorpi, O P Kallioniemi, T Koivula, et al.Journal of the National Cancer Institute|June 3, 1992
Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulationT Visakorpi, O P Kallioniemi, A Heikkinen, et al.Cancer Causes & Control : CCC|August 24, 2010
Exogenous sex hormone use and risk of meningioma: a population-based case-control study in FinlandK Korhonen, J Raitanen, J Isola, et al.The American Journal of Pathology|May 1, 1993
Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferationH Haapasalo, J Isola, P Sallinen, et al.Experimental and Molecular Pathology|December 1, 1991
Macromolecular composition of the myotendinous junctionM Järvinen, P Kannus, M Kvist, et al.Cancer|March 1, 1990
Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic countJ J Isola, H J Helin, M J Helle, et al.British Journal of Cancer|August 1, 1994
Overexpression of p53 and long-term survival in colon carcinomaA Auvinen, J Isola, T Visakorpi, et al.Pageof 17